Annual Total Debt
N/A
31 December 2023
Summary:
AcelRx Pharmaceuticals annual total debt is not available.ACRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
N/A
31 December 2023
Summary:
AcelRx Pharmaceuticals quarterly total debt is not available.ACRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ACRX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
AcelRx Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $3.37 M(-67.7%) |
| Dec 2022 | $10.42 M(-44.0%) | $10.42 M(-16.4%) |
| Sept 2022 | - | $12.47 M(-13.3%) |
| June 2022 | - | $14.39 M(-13.4%) |
| Mar 2022 | - | $16.62 M(-10.8%) |
| Dec 2021 | $18.62 M(-27.3%) | $18.62 M(-8.7%) |
| Sept 2021 | - | $20.40 M(-10.4%) |
| June 2021 | - | $22.76 M(+11.7%) |
| Mar 2021 | - | $20.37 M(-20.4%) |
| Dec 2020 | $25.60 M(-14.0%) | $25.60 M(-7.4%) |
| Sept 2020 | - | $27.65 M(-8.4%) |
| June 2020 | - | $30.20 M(+0.1%) |
| Mar 2020 | - | $30.17 M(+1.4%) |
| Dec 2019 | $29.76 M(+148.2%) | $29.76 M(+3.2%) |
| Sept 2019 | - | $28.84 M(+0.3%) |
| June 2019 | - | $28.77 M(+89.5%) |
| Mar 2019 | - | $15.18 M(+26.6%) |
| Dec 2018 | $11.99 M(-37.2%) | $11.99 M(-13.6%) |
| Sept 2018 | - | $13.87 M(-11.5%) |
| June 2018 | - | $15.68 M(-10.0%) |
| Mar 2018 | - | $17.41 M(-8.8%) |
| Dec 2017 | $19.10 M(-11.4%) | $19.10 M(-14.8%) |
| Sept 2017 | - | $22.41 M(+1.7%) |
| June 2017 | - | $22.02 M(+1.8%) |
| Mar 2017 | - | $21.64 M(+0.4%) |
| Dec 2016 | $21.55 M | $21.55 M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | $21.32 M(-0.1%) |
| June 2016 | - | $21.35 M(+1.0%) |
| Mar 2016 | - | $21.13 M(+1.0%) |
| Dec 2015 | $20.92 M(-15.9%) | $20.92 M(+1.0%) |
| Sept 2015 | - | $20.72 M(-10.4%) |
| June 2015 | - | $23.13 M(-8.0%) |
| Mar 2015 | - | $25.14 M(+1.1%) |
| Dec 2014 | $24.87 M(+73.2%) | $24.87 M(+0.0%) |
| Sept 2014 | - | $24.87 M(+0.9%) |
| June 2014 | - | $24.64 M(+70.0%) |
| Mar 2014 | - | $14.49 M(+0.9%) |
| Dec 2013 | $14.36 M(-10.1%) | $14.36 M(+36.6%) |
| Sept 2013 | - | $10.52 M(-15.1%) |
| June 2013 | - | $12.39 M(-12.8%) |
| Mar 2013 | - | $14.21 M(-11.1%) |
| Dec 2012 | $15.97 M(-16.3%) | $15.97 M(-9.7%) |
| Sept 2012 | - | $17.68 M(-8.5%) |
| June 2012 | - | $19.34 M(+0.8%) |
| Mar 2012 | - | $19.18 M(+0.5%) |
| Dec 2011 | $19.08 M(+58.9%) | $19.08 M(+114.9%) |
| Sept 2011 | - | $8.88 M(+1.6%) |
| June 2011 | - | $8.73 M(+118.7%) |
| Mar 2011 | - | $3.99 M(-66.7%) |
| Dec 2010 | $12.01 M(+23.4%) | $12.01 M(+88.2%) |
| Sept 2010 | - | $6.38 M(>+9900.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $9.73 M(-21.1%) | $9.73 M |
| Dec 2008 | $12.33 M | - |
FAQ
- What is the all time high annual total debt for AcelRx Pharmaceuticals?
- What is the all time high quarterly total debt for AcelRx Pharmaceuticals?
What is the all time high annual total debt for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high annual total debt is $29.76 M
What is the all time high quarterly total debt for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals all-time high quarterly total debt is $30.20 M